yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Table
SPARQL
Graphs
2
2
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47351169-0E192AF2-B755-4CA0-B0D0-8384C09DEB00
Q47351169-0E192AF2-B755-4CA0-B0D0-8384C09DEB00
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47351169-0E192AF2-B755-4CA0-B0D0-8384C09DEB00
Targeted therapies in non-small cell lung cancer: a focus on ALK/ROS1 tyrosine kinase inhibitors.
P2860
Q47351169-0E192AF2-B755-4CA0-B0D0-8384C09DEB00
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47351169-0E192AF2-B755-4CA0-B0D0-8384C09DEB00
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7f50d2b5e022f50f3f06d0bef8317e3fe7317cdc
P2860
Crizotinib in ROS1-rearranged non-small-cell lung cancer.